Suresnes (France), December 5, 2023 – Servier announces the appointment of Nicolas Garnier as Chief Patient Officer, effective from December 4, 2023. He takes over from Bertrand Renaud, who will retire at the end of January 2024.

Reporting to Arnaud Lallouette, Executive Vice President Global Medical & Patient Affairs, Nicolas Garnier leads Global Patient Affairs department, whose mission is to integrate the voice of the patient at each stage of the drug lifecycle. His main objective is to coordinate, promote and develop patient engagement among all Group employees and global subsidiaries, working closely with patients and the organizations that represent them.

By doing this, Nicolas Garnier will continue the key work begun by Bertrand Renaud which aimed at reinforcing the patient culture within the Group and the dynamic of working collaboratively with patients and their organizations. The Group currently spearheads over 250 such initiatives, which address very real problems, from the phase of diagnosis to the correct use of treatment. Servier has also been ranked second this year on the list of the most reputed pharmaceutical companies working with oncology patient organizations, according to the PatientView Report 2022 survey.